DAWN AC Newsletters – 2015

December 2015

Don’t miss out on the DAWN AC Benchmarking service
DAWN INR Capture
Customer Support Resources
UK User Group Proceedings Document
The importance of upgrading your DAWN AC system
Anticoagulant Risk-Benefit Analysis for Traveling Afib Patients
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA)
Warfarin transition appears tolerable in patients with cancer-associated thrombosis

November 2015

Support desk holiday closures
DAWN AC UK user group presentations now available online
NOAC module updates
Interactions with other systems
The dangers of copying and pasting
Windows 2012 server upgrades – access and permissions with DAWN AC
Adherence lapses common with NOACs early in treatment
ATRIA score accurately identifies patients at low risk for stroke
Anticoagulation Rx expanded after NOAC launch

October 2015

Marking clinics as ‘not in use’ and ‘extending’ clinics – best practice
Last chance to register for the DAWN AC North American User Group
Work Smarter – Version 7.9.45 – 7.9.47 4S
DAWN attending the AiP/NEQAS/BSHT Meeting
Bridging Anticoagulation for Patients with Atrial Fibrillation Who Are on Warfarin and Scheduled for Surgery
Thousands of atrial fibrillation patients in England are at risk of preventable stroke
New Warfarin Measure Aids in Anticoagulation Ranking

September 2015

Important Information for customers – Server/PC/Internal IT system upgrades and replacements
23rd DAWN AC UK User Group – 5th-6th October
9th DAWN AC North American User Group – 20th November
4S DAWN attending the Anticoagulation in Practice/NEQAS/BSHT Meeting
National Institute for Health and Care Excellence (NICE) recommends Daiichi’s once-daily Lixiana to prevent stroke, systemic embolism in patients with non-valvular atrial fibrillation (NVAF)
Apixaban cost-effective in AF patients with low stroke risk
Idarucizumab may quickly reverse Dabigatran effects before emergency surgery
Low bleeding and stroke rates in AF patients given Rivaroxaban for stroke prevention

August 2015

Support Desk Holiday Closures
23rd DAWN AC UK User Group – 5th-6th October
9th DAWN AC North American User Group – 20th November
Work Smarter – Version 7.9.44
FREE Online Training Resources
21st Century Benchmarking
World Thrombosis Day – October 13th
NOACs for Prevention Beyond Atrial Fibrillation?
Older Stroke Patients May Not Get Needed Anticoagulant Therapy
Heparin Still Favored for Treating Venous Thromboembolism in Cancer Patients

July 2015

23rd DAWN AC UK User Group – 5th-6th October
9th DAWN AC North American User Group – 20th November
The importance of upgrading your DAWN AC system
Regular backups of your system are essential
Important miss/boost dose settings in your DAWN AC system
Lower risk blood clot treatment ’empowers’ patients
Provisional green light for anti-clotting drug and quality standard for atrial fibrillation
Extending anticoagulation duration cuts risk of VTE recurrence

June 2015

Customer Support Resources
23rd DAWN AC UK User Group – 5th & 6th October 2015
9th Annual DAWN AC North American User Group – 20th November 2015
Work Smarter – Latest Release, Version 7.9.43
Practices to provide warfarin clinics under CCG agreement
Managing the risk of bleeding with new oral anticoagulants
The latest lessons in anticoagulation safety

May 2015

Free Online Training Resources
DAWN AC Reports Resource Page
New Benchmarking Service
Customer Support Documentation
Work Smarter – Latest Release, Version 7.9.42
A better alternative to the INR? – Warfarin monitoring with the Fiix-PT test
Managing the risk of bleeding with new oral anticoagulants
New Anticoagulant Approved by FDA for DVT and PE

April 2015

DAWN INR Capture
Text Message/SMS & Email Functionality
Variance Growth Rate Measurement
VTE Diagnosis & Assessment
Integration with Primary Care Systems
NOAC Modules – Apixaban, Rivaroxaban and Dabigatran
Medication Interface

March 2015

Support desk holiday closures
NEW SMS/Email Functionality from DAWN
23rd DAWN AC UK User Group – 5th & 6th October 2015
Come and visit us at the AC Forum
DAWN AC North American User Group 2015
Recommendations for your DAWN system: Test and Live
21st Century Benchmarking
Many with AF qualify for oral anticoagulation therapy under new guidelines
Genetic analysis can predict bleeding risk in warfarin users
Boston Scientific announces successful implantations of WATCHMAN Device in three US patients

February 2015

23rd DAWN AC UK User Group – 5th & 6th October 2015
Come and visit us at the AC Forum
Take a look at all of the DAWN AC training resources
Microsoft 2003 server support withdrawn
Marking clinics as ‘not in use’ – best practice
New treatment could lead to breakthrough in stroke treatment
European label update of Bayer’s Xarelto(R) now including guidance for use in patients with atrial fibrillation undergoing cardioversion
Findings may help with the management of anticoagulant-related bleeding within the brain

January 2015

Work smarter in 2015 – latest release 7.9.40
Marking clinics as ‘not in use’ – best practice
21st Century Benchmarking
Safely backing up your database
Higher rates of VTE found among patients with inflammatory rheumatologic diseases
Activity decreases bleeding risk from anticoagulation meds
Study suggests routine bridging harmful for A-fib patients interrupting anticoagulation